New Hope
-
DATABASE (383)
-
ARTICLES (707)
Co-founder and Director of Technology of Xurya
Edwin Widjonarko spent almost 6 years working as a research assistant at the USA’s National Renewable Energy Laboratory and at University of Colorado Boulder. In some of the projects he worked on, Widjonarko contributed to the development of new generation solar panels. In 2015, he left the research sphere to join Intel Corporation as a technology development process engineer. He stayed on until 2018, when he left Intel and returned to Indonesia to establish Xurya, a solar power company. Working with longtime friend Gusmantara Himawan and former East Ventures associate Philip Effendy, Widjonarko now works as Xurya’s director of technology.
Edwin Widjonarko spent almost 6 years working as a research assistant at the USA’s National Renewable Energy Laboratory and at University of Colorado Boulder. In some of the projects he worked on, Widjonarko contributed to the development of new generation solar panels. In 2015, he left the research sphere to join Intel Corporation as a technology development process engineer. He stayed on until 2018, when he left Intel and returned to Indonesia to establish Xurya, a solar power company. Working with longtime friend Gusmantara Himawan and former East Ventures associate Philip Effendy, Widjonarko now works as Xurya’s director of technology.
Co-founder, CEO of Meatable
Krijn De Nood is the Dutch co-founder and CEO at cell-based meat startup Meatable, the first to claim a highly scalable culture technology with the use of pluripotent stem cells, where he has worked since 2018. He previously worked at McKinsey for six-and-a-half years in Amsterdam, New York and in Kenya. Prior to that, he worked as an equity derivatives trader at derivative trading company All Options after a short stint at Barclays Capital.De Nood holds two first degrees from the University of Amsterdam, in philosophy and in economics and finance.
Krijn De Nood is the Dutch co-founder and CEO at cell-based meat startup Meatable, the first to claim a highly scalable culture technology with the use of pluripotent stem cells, where he has worked since 2018. He previously worked at McKinsey for six-and-a-half years in Amsterdam, New York and in Kenya. Prior to that, he worked as an equity derivatives trader at derivative trading company All Options after a short stint at Barclays Capital.De Nood holds two first degrees from the University of Amsterdam, in philosophy and in economics and finance.
co-founder and CEO of YITU Healthcare
Leo Zhu received his PhD in Statistics from the University of California, Los Angeles, where he specialized in statistical modeling of computer vision and artificial intelligence (AI), He was a student of Professor Alan Yuille whose PhD in theoretical physics was supervised by Dr Stephen Hawking. Prior to co-founding and becoming the CEO of China’s leading AI technology startup YITU Healthcare, he was a postdoctoral fellow at Massachusetts Institute of Technology’s AI laboratory and a research fellow at the Courant Institute of Mathematical Sciences, New York University.
Leo Zhu received his PhD in Statistics from the University of California, Los Angeles, where he specialized in statistical modeling of computer vision and artificial intelligence (AI), He was a student of Professor Alan Yuille whose PhD in theoretical physics was supervised by Dr Stephen Hawking. Prior to co-founding and becoming the CEO of China’s leading AI technology startup YITU Healthcare, he was a postdoctoral fellow at Massachusetts Institute of Technology’s AI laboratory and a research fellow at the Courant Institute of Mathematical Sciences, New York University.
Founded in Shenzhen in 2013, HNF focuses on industries such as mobile internet, entertainment, healthcare and education. It was named one of China’s New Investment Organization’s Top 20 companies for 2017.
Founded in Shenzhen in 2013, HNF focuses on industries such as mobile internet, entertainment, healthcare and education. It was named one of China’s New Investment Organization’s Top 20 companies for 2017.
Founded in 2014, Stellar Kapital is a VC and investment firm that seeks to empower new entrepreneurs and launch new tech events including a cultural and music Stellar Fest in 2018. Its first fund of US$10 million was mainly invested in real-sector companies. Armed with a second investment fund of US$25 million, Stellar Kapital is looking to invest in startups with funding ranging from US$200,000 to US$1 million. The VC also invests directly in offline companies like co-working business Freeware Spaces, Stellar Parking and Divestekno, an oil and gas company.
Founded in 2014, Stellar Kapital is a VC and investment firm that seeks to empower new entrepreneurs and launch new tech events including a cultural and music Stellar Fest in 2018. Its first fund of US$10 million was mainly invested in real-sector companies. Armed with a second investment fund of US$25 million, Stellar Kapital is looking to invest in startups with funding ranging from US$200,000 to US$1 million. The VC also invests directly in offline companies like co-working business Freeware Spaces, Stellar Parking and Divestekno, an oil and gas company.
The Alexa Fund provides up to $200 million in venture capital funding to fuel voice technology innovation. It is focused on how voice technology can improve customers’ lives, from early-stage pre-revenue companies to established brands. Areas of particular interest include: hardware products that would benefit from the Alexa Voice Service; skills that deliver new abilities to Alexa-enabled devices through the Alexa Skills Kit; and new contributions to the science behind voice technology, including text to speech, natural language understanding, automatic speech recognition, artificial intelligence and hardware component design.
The Alexa Fund provides up to $200 million in venture capital funding to fuel voice technology innovation. It is focused on how voice technology can improve customers’ lives, from early-stage pre-revenue companies to established brands. Areas of particular interest include: hardware products that would benefit from the Alexa Voice Service; skills that deliver new abilities to Alexa-enabled devices through the Alexa Skills Kit; and new contributions to the science behind voice technology, including text to speech, natural language understanding, automatic speech recognition, artificial intelligence and hardware component design.
Formerly known as Tribeca Angels, the New York-based Tribeca Early Stage Partners was established in 2014 by John McEvoy. The firm's network of 50 entrepreneurs and business leaders specialize in institutional finance and enterprise technology. Tribeca focuses on early-stage investments in fintechs and ERPs, especially those based in the New York area. Initial investment per startup ranges from US$500,000 to US$1 million. It has invested in 15 startups and managed two exits, Cola and James.
Formerly known as Tribeca Angels, the New York-based Tribeca Early Stage Partners was established in 2014 by John McEvoy. The firm's network of 50 entrepreneurs and business leaders specialize in institutional finance and enterprise technology. Tribeca focuses on early-stage investments in fintechs and ERPs, especially those based in the New York area. Initial investment per startup ranges from US$500,000 to US$1 million. It has invested in 15 startups and managed two exits, Cola and James.
BDMI is a New York-based VC company that is part of the global media group, Bertelsmann, which backs mainly companies in the new digital media ecosystem. The company usually invests through Series A and Series B rounds ranging from US$500,000 to US$5 million with reserves for follow-ons.Companies backed by BDMI get access to a vast network of media companies in the Bertelsmann group and benefit from their extensive media expertise with a global perspective.The firm’s portfolio includes startups from North America, Europe and Israel.
BDMI is a New York-based VC company that is part of the global media group, Bertelsmann, which backs mainly companies in the new digital media ecosystem. The company usually invests through Series A and Series B rounds ranging from US$500,000 to US$5 million with reserves for follow-ons.Companies backed by BDMI get access to a vast network of media companies in the Bertelsmann group and benefit from their extensive media expertise with a global perspective.The firm’s portfolio includes startups from North America, Europe and Israel.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
China’s third most popular bike-sharing app provides differentiated services, such as lower rates and electronic parking stations.
China’s third most popular bike-sharing app provides differentiated services, such as lower rates and electronic parking stations.
CEO and Co-founder of 17zuoye
Former senior teacher and executive at New Oriental Education & Technology Group Inc., the largest provider of private educational services in China. He singlehandedly founded its office in Changchun. Described by Xiaomi CEO and founder Lei Jun as “a founder without flaws”.
Former senior teacher and executive at New Oriental Education & Technology Group Inc., the largest provider of private educational services in China. He singlehandedly founded its office in Changchun. Described by Xiaomi CEO and founder Lei Jun as “a founder without flaws”.
Co-founder and CEO of Astronaut Technologies
After six years of building innovative products and new businesses in Singapore and India, Nigel Hembrow has made Indonesia his home and headquarters for Astronaut Technologies, his latest venture in HR tech. Hailing from Australia, Queensland civil engineer Nigel started out in project management and engineering design for construction company Mace. After an MBA from the University of Melbourne in 2009, he worked at The Great Little Water Company and Amida Recruitment. Nigel is also currently a director at Rayjon Group, a family-owned property investment and development conglomerate that was co-founded by managing director John Hembrow in 1976.
After six years of building innovative products and new businesses in Singapore and India, Nigel Hembrow has made Indonesia his home and headquarters for Astronaut Technologies, his latest venture in HR tech. Hailing from Australia, Queensland civil engineer Nigel started out in project management and engineering design for construction company Mace. After an MBA from the University of Melbourne in 2009, he worked at The Great Little Water Company and Amida Recruitment. Nigel is also currently a director at Rayjon Group, a family-owned property investment and development conglomerate that was co-founded by managing director John Hembrow in 1976.
Co-founder and co-CEO of Shotl
Osvald Martret is the chairman of Drivania Chauffeurs co-founded by the Martret brothers in 2001, now transformed into Drivania International with operations in Europe and the US. In 2001, the Martrets also established mobility venture builder Camina Lab in New York.Martret graduated in Nautical Science at Barcelona Polytechnic University and has a master's in International Transport from Pontificia de Comillas University in Madrid. He worked as a transport manager at MAXAM that transports dangerous substances and was operations manager at shipping agency Transcoma. In 2016, he became co-CEO of Shotl, another Martret transportation startup in Barcelona.
Osvald Martret is the chairman of Drivania Chauffeurs co-founded by the Martret brothers in 2001, now transformed into Drivania International with operations in Europe and the US. In 2001, the Martrets also established mobility venture builder Camina Lab in New York.Martret graduated in Nautical Science at Barcelona Polytechnic University and has a master's in International Transport from Pontificia de Comillas University in Madrid. He worked as a transport manager at MAXAM that transports dangerous substances and was operations manager at shipping agency Transcoma. In 2016, he became co-CEO of Shotl, another Martret transportation startup in Barcelona.
Co-founder and COO of Halodoc
Doddy Lukito has over 19 years of experience in both corporate management and technology roles. After earning a master's in Computer Engineering from Carnegie Mellon University, USA, he worked at New York based software company TenFold between 1999 and 2003. Doddy later returned to Indonesia, joining software consulting firm infinITechnology and International Investment Communication Network. He also had a brief lecturing stint at Universitas Bina Nusantara. Doddy had previously co-founded Bistip, a peer-to-peer courier service startup, after which he joined pharmaceutical conglomerate Mensa Group through doctors-only social media LinkDokter, which was later the basis for healthcare platform Halodoc.
Doddy Lukito has over 19 years of experience in both corporate management and technology roles. After earning a master's in Computer Engineering from Carnegie Mellon University, USA, he worked at New York based software company TenFold between 1999 and 2003. Doddy later returned to Indonesia, joining software consulting firm infinITechnology and International Investment Communication Network. He also had a brief lecturing stint at Universitas Bina Nusantara. Doddy had previously co-founded Bistip, a peer-to-peer courier service startup, after which he joined pharmaceutical conglomerate Mensa Group through doctors-only social media LinkDokter, which was later the basis for healthcare platform Halodoc.
CEO and Co-founder of Proppos FastPay
Nil Salomó Bellavista holds a Masters in Biotechnology and Bioengineering with a specialization in the field of tissue engineering. He worked on building a new 3D printing technique for organs before switching to AI. To do so, Bellavista embarked on a project to apply this technology to the hospitality industry, testing it out at the Nostrum outlet, a self-service food franchise, that he co-owns. The result is Proppos FastPay, an intelligent self-checkout solution powered by computer vision. Founded in 2018, Proppos is currently finalizing pilots with international clients and preparing for its official, commercial launch in 2020.
Nil Salomó Bellavista holds a Masters in Biotechnology and Bioengineering with a specialization in the field of tissue engineering. He worked on building a new 3D printing technique for organs before switching to AI. To do so, Bellavista embarked on a project to apply this technology to the hospitality industry, testing it out at the Nostrum outlet, a self-service food franchise, that he co-owns. The result is Proppos FastPay, an intelligent self-checkout solution powered by computer vision. Founded in 2018, Proppos is currently finalizing pilots with international clients and preparing for its official, commercial launch in 2020.
Beyond billion dollar investment rounds, Indonesia and Singapore are working together to harness the potential of their startup ecosystems
Bukalapak CEO Achmad Zaky steps down, ex-banker Rachmat Kaimuddin to take over
Rumors of a leadership change first surfaced in August as the Indonesian unicorn and its co-founder got a bad press
P2P lender Investree collaborates with eFishery to provide loans for aquaculture SMEs
Access to quick financing would be a welcome relief to fish farmers, whose incomes have been battered by Covid-19, but can’t get bank loans
Node: Fighting deforestation with fashionable footwear from agricultural waste
Using patented technology developed with Indonesia’s Ministry of Agriculture, Node turns farm waste and plant materials into biodegradable vegan footwear and shoe components to help fight deforestation.
Dao Foods: Grooming and betting on China's rising alternative protein startups
How can businesses involve Chinese consumers in the environmental cause, even if it isn’t a priority for them? For that, the impact investor-incubator Dao Foods has got its philosophy-led strategy figured out
8villages is one of the first agritech startups in Indonesia, and the social media for farmers has since expanded into e-commerce and agriculture data collection
More Asian men are into skincare and health products, and Elio is here to help (discreetly)
Elio believes offering privacy, free online consultations and discreet product packaging will encourage more men to take better care of their health
Founder and CEO Gao Lufeng on Ninebot's acquisition of American motorized scooter maker Segway, China’s rise in technology and innovation, and the company’s plans for the US market
Ruangguru cracks business model as it reaches 13 million student users
Holding pole position as Indonesia's popular tutoring services app, Ruangguru is revving up to expand into the lucrative corporate training sector
Raw Data: Bringing new predictability to harvests
Spanish ML, big data startup helps farmers perfect wine and fruit production in a fast-growing precision agtech sector
Xing Nong Fu: Using earthworms to create sustainable local farming and livelihoods
Worm castings can rehabilitate infertile land due to excessive soil salinity in just seven days, compared with three to five years using traditional methods, and 90% more cheaply
Portofolio: Showing rookie investors the ropes without the rip-offs
Through investment education and the guidance of master traders, Portofolio aims to show aspiring forex and derivatives traders and investors how to avoid scams and stabilize their returns
With a new focus on smart clinics, healthcare SaaS startup Medigo offers Covid-19 testing
A pivot to revenue-sharing and partnerships to provide Covid-19 testing has given Medigo a fighting chance, with a new funding round on the cards
Xiangwushuo’s platform finds a new home for secondhand goods
This WeChat mini program doesn’t yet have a monetization strategy, but has still received over US$110 million in funding in one year
A new unicorn rises as OVO's $1bn valuation confirmed
The Lippo Group subsidiary continues to grow in strength as it battles for market share with Gojek’s e-wallet and others
Sorry, we couldn’t find any matches for“New Hope”.
POPULAR DATABASE
